clorazepate dipotassium has been researched along with moclobemide in 1 studies
| Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (moclobemide) | Trials (moclobemide) | Recent Studies (post-2010) (moclobemide) |
|---|---|---|---|---|---|
| 325 | 90 | 11 | 788 | 240 | 113 |
| Protein | Taxonomy | clorazepate dipotassium (IC50) | moclobemide (IC50) |
|---|---|---|---|
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 7.7 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.1522 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrer-Dufol, A; Marques-Alamo, JM; Murillo, EC; Perez-Aradros, C | 1 |
1 other study(ies) available for clorazepate dipotassium and moclobemide
| Article | Year |
|---|---|
Fatal serotonin syndrome caused by moclobemide-clomipramine overdose.
Topics: Adult; Benzamides; Clomipramine; Clorazepate Dipotassium; Drug Interactions; Drug Overdose; Fatal Outcome; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |